RAP 0.00% 20.5¢ resapp health limited

My Analysis: No synergy value in valuation, page-29

  1. 6,719 Posts.
    lightbulb Created with Sketch. 850
    Except OZZY you have omitted the very real possibility of a competing bid that forced Pfizer to raise their offer. Omission of the admission that BOD were not aware of any competing bid has just about popped the cat out of the bag IMHO. Take this scenario into account. DYOR
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.